Skip to main content
. 2021 Mar 30;12:1967. doi: 10.1038/s41467-021-22177-1

Fig. 2. Kaplan–Meier analyses of the primary and key secondary outcome in the intention-to-treat population.

Fig. 2

a Time until cessation of SARS-CoV-2 viral shedding from oropharyngeal swabs stratified by treatment arm, Lambda (blue) vs. placebo (red). b Time until resolution of all symptoms stratified by treatment arm, Lambda (blue) vs. placebo (red). In both panels, solid lines represent Kaplan–Meier survival probability; shading represents 95% confidence intervals. Source data available at https://purl.stanford.edu/hc972ys6733.